EFDID: 579633EFD: View Filing

Issuer: Nacuity Pharmaceuticals, Inc. (0001690279) - D

Accession: 0001690279-25-000002 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001690279
  • Entity Name:
    Nacuity Pharmaceuticals, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Over 5 years ago
  • Address:
    FORT WORTH CLUB BLDG.
    306 W. 7TH STREET, SUITE 310
    FORT WORTH, TX 76102
  • Persons:
    Related Persons 10
    Halden Conner
    Executive Officer, Director
    David Wohlberg
    Executive Officer, Director
    Gerald Cagle
    Director
    Emmett Cunningham, Jr.
    Director
    Rusty Kelley
    Director
    Robin Steele
    Director
    Benjamin Yerxa
    Director
    Jami Kern
    Executive Officer
    Charles Lieser
    Executive Officer
    Michael Wall
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    12/29/2025
  • First Sale Date:
    12/11/2025
  • Offering Amount:
    $30,000,000
  • Amount Sold:
    $8,393,350
  • Amount Remaining:
    $21,606,650
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity, Debt, Convertible Promissory Notes convertible into preferred stock or common stock, Common Stock Purchase Warrants, Common Stock issued for Warrant Conversion
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Maxim Group LLC 120708 None None All States
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Nacuity Pharmaceuticals, Inc.Halden ConnerHalden ConnerPresident and Chief Executive Officer2025-12-29